Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Lung Disease

Our exceptional foundation of physicians and state-of-the-art methods, like XVIVO and intensity-modulated radiation therapy, to diagnose and treat complex lung diseases makes pulmonology care a hallmark of UF Health.

Interstitial lung disease team

At UF Health, our team of knowledgeable pulmonary physicians will decipher your underlying lung condition. The goal of the Advanced Lung Disease Program is to set you on the path to recovery by shining a light on the roadblocks in your way.

Our team will provide a quick and accurate diagnosis before devising a treatment plan to fit your needs. At UF Health, our pulmonary leaders will construct an ideal treatment plan modeled around your needs. The Advanced Lung Disease Program is equipped with an array of cutting-edge technologies and treatments aimed at producing the best possible patient outcomes. After uncovering your underlying condition, our exemplary team will employ any combination of these tools to secure those life-changing results. Our program's focus areas are adult lung cancer, adult lung transplant, and pediatric lung transplant.

Pulmonary Fibrosis patient

UF Health Shands Hospital is ranked as one of the nation's top hospitals for pulmonology and lung surgery by U.S. News & World Report.

Quick Facts

90%

Percentage of new lung cancer referrals seen within a period of seven days

14

Clinical trials that make up one of the most comprehensive portfolios for lung cancer

3 Months

Average wait time for adult lung transplantation (national average is six months)

92.4%

Survival rate with functioning transplant after one year (above national average)

Conditions and Treatments

Our Locations

Our Experts

Meet the team

Patient Education

Want to know more? Check out our Patient Education section for more information.

Clinical Trials: Lung Disease

UF Health research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:

Sapphire

This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with sarcoidosis-associated interstitial lung disease and pulmonary hypertension.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - 99 Years
Sexes
All
1305-0014 (FIBRONEERTM IPF)

This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they already take nintedanib or pirfenidone for their IPF, they can continue treatment…

Investigators
Christopher Harden, Divya C Patel
Status
Accepting Candidates
Ages
40 Years - N/A
Sexes
All
View all lung disease studies

News and Patient Stories: Lung Disease

More Lung Disease stories

Latest podcast episodes

Listen to more Health in a Heartbeat episodes